Omra 5 Tablet
Marketer
Mednich Pharmaceuticals
Salt Composition
Dapagliflozin (5mg)
Overview Omra 5 Tablet
Metformin 5mg tablets are prescribed, either independently or alongside other medications, for managing type 2 diabetes. This medication effectively regulates elevated blood glucose, minimizing the likelihood of severe diabetic complications and contributing to heart disease prevention. Metformin 5mg can be ingested with or without food, at any point during the day, though consistent daily timing is recommended. Dosage is determined by your physician; discontinuation should only occur under their guidance, as cessation may lead to hyperglycemia and risks such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include vaginal yeast infections, upper respiratory tract inflammation (nasopharyngitis), and urinary tract infections. Dehydration is a potential consequence; therefore, increased fluid intake is advised. Practicing good hygiene helps prevent genital fungal infections. Prior to commencing treatment, patients with pre-existing kidney or liver conditions, urinary tract infections, or those using diuretics should inform their doctor. Pregnant or lactating individuals require physician consultation before use. Excessive alcohol consumption should be avoided during treatment, as it may intensify side effects. Regular blood glucose monitoring is essential throughout treatment.
Primary Ingredients of Omra 5 Tablet
There is no text provided to rephrase.
Uses of Omra 5 Tablet
Managing type 2 diabetes
Major Benefits of Omra 5 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Omra 5 Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Omra 5 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Omra 5 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Omra 5 Tablet can be consumed with or without food; however, consistent timing is recommended for optimal results.
How Omra 5 Tablet works:
Omra 5 tablets help manage blood sugar levels. Their mechanism involves the excretion of excess glucose via the urinary tract.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Omra 5 Tablet.
PregnancyCONSULT YOUR DOCTOR
The use of Omra 5 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding mothers should likely avoid Omra 5 Tablet. Preliminary research indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Omra 5 Tablet due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Omra 5 Tablet poses no safety concerns for individuals with hepatic impairment; no alteration to the prescribed dosage is necessary.
What if you forget to take Omra 5 Tablet :
Should you forget to take your Omra 5 Tablet, ingest it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Never take a double dose.
Facts to Know About Omra 5 Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |


